AI-generated summary
This review describes chronotherapy, including sleep deprivation, bright light therapy and sleep phase advance, as non-drug options for depression that may help drug-resistant patients. The authors report a high response rate of approximately 60% for sleep deprivation, but note that relapse is common and that efficacy can be increased or sustained when combined with medication, light therapy or sleep phase advance. The abstract does not describe a specific study sample or design.
- Who or what was studied
- Patients with depression, including those resistant to drug treatment
- Limits stated in the abstract
- The abstract notes that relapse is common and that the treatment is not widely used in Japan, and it does not report the number or design of included studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Depression, Bright light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.